Deucravacitinib safer and more effective than apremilast for treating moderate to severe scalp psoriasis

Press/Media

Period	1 Feb 2024

Media coverage

Title	Deucravacitinib safer and more effective than apremilast for treating moderate to severe scalp psoriasis
Media name/outlet	Medical Dialogues
Country/Territory	India
Date	1/02/24
URL	ct.moreover.com/?a=52992978475&p=1gw&v=1&x=3iSgwhkedzQ495Clgb9wLw
Persons	Mark Lebwohl